Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
MEDEXEL from Sint-Jans-Molenbeek, company number BE0440342980, closed financial year 2025 with a result of € -2 million after tax. For that financial year MEDEXEL recorded revenue of € 10.3 million and equity of € 690,641. Compared with financial year 2024, the result moved from € -2.9 million to € -2 million. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 690,641
▲ € 2 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2 million
▲ 32 % less loss than in 2024
Profit after tax over the fiscal year.
€ 7,961
▼ € 5.3 million vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -8.8 million.
People and assets in 2025
90.3
▼ 25.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 8.1 million
▲ 4% vs 2024
€ 89,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 866,552
▼ 40% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 67 days on average.
€ 1.1 million
▼ 42% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 9,094,735 | € 9,957,309 | € 9,667,194 | € 10,329,723 | ▲ 7% |
| Profit after taxes | € -411,691 | € -2,228,963 | € -2,889,987 | € -1,979,058 | ▲ € 910,929 |
| Equity | € -211,127 | € 1,559,798 | € -1,330,189 | € 690,641 | ▲ € 2 million |
| Total debts | € 21,079,621 | € 34,376,018 | € 49,994,684 | € 20,653,414 | ▼ 59% |
| Cash | € 6,307,491 | € 479,381 | € 5,258,703 | € 7,961 | ▼ € 5.3 million |
| Retained profit | € -1,744,037 | € -3,973,000 | € -6,862,988 | € -8,842,046 | ▼ € 2 million |
| Bank debt | € 10 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 20,868,494 | € 35,935,816 | € 48,664,495 | € 21,964,223 | ▼ 55% |
| Employees (FTE) | 100.8 | 115 | 115.4 | 90.3 | ▼ 25.1 |
Key figures of MEDEXEL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDEXEL?
What happened at MEDEXEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- JEAN WALLEMACQ stepped down as director. NBB
- VINCENT JONCKHEERE stepped down as director. NBB
- JOSEPH DUMORTIER stepped down as director. NBB
- ALEX PARISEL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2 million. Source: NBB ↗
- JEAN WALLEMACQ became a director. NBB
- VINCENT JONCKHEERE became a director. NBB
- JOSEPH DUMORTIER became a director. NBB
In short
From € 411,691 loss in 2022 to € 2 million loss in 2025.
Paid € 19,872 in corporate taxes since 2022.
Pays suppliers within 67 days on average.
A new publication or filing at MEDEXEL? We notify you, reason included.
Follow MEDEXELDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by PARTENA PROMERIS ASBL (100%).
Directors
According to the 2025 annual accounts
since 2022 · until 2028
VINCENT JONCKHEERE
Chairman of the board
Also active at: PARTENA - SECRETARIAT SOCIAL D'EMPLOYEURS - PARTENA - SOCIAAL SECRETARIAAT VOOR werkgevers, PROMERIS SERVICES, Centre d'Initiatives et d'Actions Santé, C. L. U. INVEST, PARTENA BUSINESS SOLUTIONS, PARTENA PROMERIS, CAREVOLUTION, Solumob Wallonie +12 more
since 2022 · until 2028
JOSEPH DUMORTIER
Managing director
since 2022 · until 2028
ALEX PARISEL
Director
Also active at: PROMERIS SERVICES, PARTENA PROMERIS, CAREVOLUTION, ROSA, PARTENA
since 2022 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Louis Mettewielaan 74-76
1080 Sint-Jans-Molenbeek
Louis Mettewielaan 74 7
1080 Sint-Jans-Molenbeek
Active since 27 March 1990
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0440.342.980
- VAT number
- BE 0440.342.980
- Registered office
- Louis Mettewielaan 74-76, 1080 Sint-Jans-Molenbeek
- Names & denominations
- MEDEXEL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 March 1990
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Ondersteunende activiteiten in verband met verzekeringen en pensioenfondsen, neg